Rommel Christian 4
4 · CRISPR Therapeutics AG · Filed May 31, 2024
Insider Transaction Report
Form 4
Rommel Christian
Director
Transactions
- Award
Stock Option (Right to Buy)
2024-05-30+26,000→ 26,000 totalExercise: $54.06Exp: 2034-05-30→ Common Shares (26,000 underlying)
Footnotes (1)
- [F1]This option was granted on May 30, 2024 with respect to 26,000 Common Shares, with 100% of the shares vesting in 36 equal monthly installments beginning on June 30, 2024.